Enhancement of delayed-type hypersensitivity and induction of interferon by the lipophilic agents DDA and CP-20,961.
D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D003959:Diamines / Q000494:pharmacology*; D004686:Encephalomyocarditis virus / Q000276:immunology; D006968:Hypersensitivity, Delayed / Q000276:immunology*; D007369:Interferon Inducers / Q000494:pharmacology*; D007372:Interferons / Q000032:analysis; D051379:Mice; D008807:Mice, Inbred BALB C; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D012672:Semliki forest virus / Q000276:immunology
D000276:Adjuvants, Immunologic; D000914:Antibodies, Viral; D003959:Diamines; D007369:Interferon Inducers; D000644:Quaternary Ammonium Compounds; C015831:dimethyldioctadecylammonium; D007372:Interferons; C006270:avridine